Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Predicting invasive ventilation and its effect on mortality for patients with pneumonia: an observational study using machine learning and a target trial approach

FY 2020-21

Summary
Pneumonia is a common, dangerous, and treatable cause of mortality and morbidity. More than 2 million people worldwide die from pneumonia each year, not including the accumulating mortality from the COVID-19 pandemic. The burden of pneumonia falls disproportionately on people made vulnerable by poverty, insecure housing, or malnutrition. Treatments focus on antibiotics and supportive care, with severe cases frequently placed on ventilatory life support also known as invasive ventilation. However, invasive ventilation comes with significant side effects including the danger of the procedure to start invasive ventilation, the risks of weakness, hospital-acquired infection, and delirium that are common during invasive ventilation, and the difficulties in communication that come from having a breathing tube prevent speech. The decision to start invasive ventilation requires careful weighing of the risks and benefits, but there is almost no data available to assist physicians and patients in making this decision. Our project will investigate the risks and benefits of invasive ventilation in patients with pneumonia according to practical clinical characteristics. We will use data from three large, detailed databases of critically ill patients featuring minute-by-minute clinical data, and we will use the innovative "target trial" method which has improved our ability to gain helpful information from observational research. This research will help motivate clinical trials to help improve our care for patients with pneumonia and it will guide patients and clinicians who are faced with the difficult decision of whether or not to start invasive ventilation when a patient is very sick with pneumonia.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
437164
Name
Yarnell Christopher J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Predicting invasive ventilation and its effect on mortality for patients with pneumonia: an observational study using machine learning and a target trial approach
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Artifical Respiration; Causal Inference; Covid-19; Critical Care Medicine; Critical Illness; Intubation; Machine Learning; Mechanical Ventilation; Pneumonia; Target Trial
Abstract
Pneumonia is a common, dangerous, and treatable cause of mortality and morbidity. More than 2 million people worldwide die from pneumonia each year, not including the accumulating mortality from the COVID-19 pandemic. The burden of pneumonia falls disproportionately on people made vulnerable by poverty, insecure housing, or malnutrition. Treatments focus on antibiotics and supportive care, with severe cases frequently placed on ventilatory life support also known as invasive ventilation. However, invasive ventilation comes with significant side effects including the danger of the procedure to start invasive ventilation, the risks of weakness, hospital-acquired infection, and delirium that are common during invasive ventilation, and the difficulties in communication that come from having a breathing tube prevent speech. The decision to start invasive ventilation requires careful weighing of the risks and benefits, but there is almost no data available to assist physicians and patients in making this decision. Our project will investigate the risks and benefits of invasive ventilation in patients with pneumonia according to practical clinical characteristics. We will use data from three large, detailed databases of critically ill patients featuring minute-by-minute clinical data, and we will use the innovative "target trial" method which has improved our ability to gain helpful information from observational research. This research will help motivate clinical trials to help improve our care for patients with pneumonia and it will guide patients and clinicians who are faced with the difficult decision of whether or not to start invasive ventilation when a patient is very sick with pneumonia.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Yarnell, Christopher J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~